Header Logo

Kimberly Lenz

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
361
0.670
 Why?
Analgesics, Opioid
4
2019
536
0.560
 Why?
Pain
3
2019
407
0.560
 Why?
Medication Therapy Management
3
2018
21
0.380
 Why?
Antiviral Agents
3
2018
322
0.320
 Why?
Practice Patterns, Physicians'
5
2019
709
0.310
 Why?
Hepatitis C
2
2016
149
0.220
 Why?
United States
10
2019
7849
0.160
 Why?
Drug Utilization Review
2
2017
52
0.160
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Drug and Narcotic Control
2
2017
28
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Benzodioxoles
1
2019
13
0.160
 Why?
Aminopyridines
1
2019
34
0.150
 Why?
Quinolones
1
2019
29
0.150
 Why?
Uridine Monophosphate
1
2018
9
0.140
 Why?
Fluorenes
1
2018
14
0.140
 Why?
Cystic Fibrosis
1
2019
121
0.140
 Why?
Benzimidazoles
1
2018
54
0.140
 Why?
Psychotropic Drugs
1
2018
84
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
19
0.140
 Why?
Hepatitis C, Chronic
1
2018
86
0.130
 Why?
Hydrocodone
1
2017
7
0.130
 Why?
Drug Prescriptions
1
2018
168
0.130
 Why?
Hepacivirus
1
2018
139
0.130
 Why?
Opioid-Related Disorders
2
2014
509
0.130
 Why?
Progesterone
1
2017
163
0.130
 Why?
Premature Birth
1
2017
112
0.120
 Why?
Medication Adherence
1
2017
204
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.110
 Why?
Lung
1
2019
955
0.110
 Why?
Prescription Drug Misuse
1
2014
21
0.110
 Why?
State Government
1
2014
32
0.110
 Why?
Drug Combinations
3
2019
165
0.110
 Why?
Drug Interactions
1
2014
127
0.100
 Why?
Managed Care Programs
1
2014
89
0.100
 Why?
Retrospective Studies
7
2018
6643
0.100
 Why?
Health Services Accessibility
1
2016
565
0.090
 Why?
Mental Disorders
1
2018
794
0.080
 Why?
Treatment Outcome
3
2016
5668
0.080
 Why?
Young Adult
4
2019
4716
0.070
 Why?
Adolescent
4
2019
6260
0.070
 Why?
Adult
6
2019
16899
0.060
 Why?
Humans
10
2019
63573
0.060
 Why?
Cost Savings
2
2016
53
0.060
 Why?
Drug Costs
2
2016
56
0.060
 Why?
Cost-Benefit Analysis
2
2017
312
0.050
 Why?
Female
7
2019
32971
0.050
 Why?
Program Evaluation
2
2018
487
0.050
 Why?
Middle Aged
5
2019
17677
0.050
 Why?
Pharmacists
2
2016
127
0.050
 Why?
Male
6
2019
29956
0.050
 Why?
Massachusetts
2
2018
2074
0.050
 Why?
Cohort Studies
2
2017
2575
0.040
 Why?
Child
2
2019
4541
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
76
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
17
0.040
 Why?
Ribavirin
1
2018
23
0.040
 Why?
Polypharmacy
1
2018
61
0.040
 Why?
Treatment Failure
1
2018
201
0.030
 Why?
Hydroxyprogesterones
1
2017
6
0.030
 Why?
Viral Load
1
2018
231
0.030
 Why?
Controlled Substances
1
2017
5
0.030
 Why?
Drug Therapy, Combination
1
2018
467
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
864
0.030
 Why?
Gestational Age
1
2017
191
0.030
 Why?
RNA, Viral
1
2018
276
0.030
 Why?
Psychiatry
1
2018
126
0.030
 Why?
Genotype
1
2018
662
0.030
 Why?
Insurance Claim Review
1
2016
76
0.030
 Why?
Evidence-Based Medicine
1
2018
462
0.030
 Why?
Pregnancy Outcome
1
2017
193
0.030
 Why?
Government Regulation
1
2014
41
0.030
 Why?
Interdisciplinary Communication
1
2014
106
0.030
 Why?
Physician's Role
1
2014
124
0.020
 Why?
Cooperative Behavior
1
2014
223
0.020
 Why?
Health Policy
1
2014
192
0.020
 Why?
Mutation
1
2019
2615
0.020
 Why?
Pregnancy
1
2017
2335
0.020
 Why?
Time Factors
1
2014
3731
0.020
 Why?
Aged
1
2018
14477
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_